HIT
Health In Tech, Inc.
Technology · Software - Application · NCM
$0.99
Data: 2026-05-15
✓ ETHICAL PASS

WEAK MOAT
HIGH
Data Confidence: 85.7%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$74M
Total market value of the company
Trailing P/E
N/A
Forward P/E
6.81
Based on estimated future earnings — lower means cheaper
Rev Growth
+9.4%
Year-over-year revenue change
Profit Margin
-2.4%
How much profit the company keeps from each dollar of revenue
ROE
-4.5%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$4.18
+324% from current price — median analyst estimate
Recommendation
STRONG_BUY
Consensus view from 3 analysts covering this stock
About Health In Tech, Inc.

Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) cards to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.

https://healthintech.com

Country: United States Industry: Software - Application
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.1% PASS
Debt must be below 33% of total assets
Cash Ratio
7.6% PASS
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
Fair Value Est.
$2.00
What our model estimates this business is worth per share
Margin of Safety
50.7%
Deep discount to fair value — significant undervaluation
Rating
OPPORTUNITY
Overall assessment combining ethics, valuation, and quality
Percentile
98.9th
Ranks in the top 1% of our 13,571 screened universe
Ethical Score
97.1
Valuation Score
95.0
Quality Score
25.0
Combined
78.6

Trading at $1 against a fair value of $2, a 43% discount. Passes all ethical screens. Ranks better than 97% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime
MARKDOWN
Price trending down — defensive positioning
Sharpe Ratio
0.027
Positive but modest risk-adjusted returns
Kelly Fraction
-0.0341
No positive edge detected — the data suggests staying out
Calmar Ratio
-0.774
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-71.6%
Historical annualised return based on price data
Max Drawdown
-92.6%
Largest peak-to-trough decline — the worst it has been
HMM State
BULL
Statistical model sees bullish momentum
Days in State
34
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

Beta
N/A
52W High
$4.02
75% below the year high
52W Low
$0.56
78% above the year low
Avg Volume
324,945
Average daily shares traded — higher means easier to buy and sell
Short Ratio
6.6
Days it would take all short sellers to cover — higher means more crowded
Short % Float
4.3%
Low short interest — limited bearish positioning
Div Yield
0.0%
Annual dividend as a percentage of the share price
EPS (TTM)
$0.02
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity
0.01
Conservative use of debt — low financial risk
Current Ratio
3.13
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
2.61
Like current ratio but excludes inventory — stricter test
Gross Margin
58.9%
Revenue left after cost of goods — higher means pricing power
Operating Margin
-24.6%
Profit from core operations before interest and tax
Free Cash Flow
$-4,286,154
Negative — the business is spending more than it generates
Revenue (TTM)
$34M
Total revenue over the last 12 months
Net Income
$-808,031
Loss-making — spending exceeds revenue after all costs
Analyst Coverage
Analysts
3
Target High
$4.55
Target Median
$4.18
Target Low
$4.00
Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date Insider Title Type Shares Value
2026-04-10 MCSTRAVOCK JOHN General Counsel 5,000 —
2026-04-08 SHRESTHA SANJAY K Director 13,598 $18,493
2026-04-08 HOWARD WILLIAM D. Director 13,598 $18,493
2026-04-08 HAYES TIMOTHY Director 13,598 $18,493
2026-01-06 JOHNSON TIM DONALD Chief Executive Officer 1,000,000 —
2026-01-06 QIAN LINLIN Chief Financial Officer 1,000,000 —
2026-01-06 HASAN ZAIN SYED Officer 200,000 —
2025-11-05 CLARKSON MICHAEL DAVID Chief Technology Officer 8,000 —
2025-10-08 SHRESTHA SANJAY K Director 5,730 $19,998
2025-10-08 HOWARD WILLIAM D. Director 5,730 $19,998
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.